I. Mender Et Al. , "Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton," INTERNATIONAL JOURNAL OF ONCOLOGY , vol.42, no.5, pp.1709-1715, 2013
Mender, I. Et Al. 2013. Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton. INTERNATIONAL JOURNAL OF ONCOLOGY , vol.42, no.5 , 1709-1715.
Mender, I., ŞENTÜRK, Ş., Ozgunes, N., AKÇALI, K. C., Kletsas, D., Gryaznov, S., ... CAN, A.(2013). Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton. INTERNATIONAL JOURNAL OF ONCOLOGY , vol.42, no.5, 1709-1715.
Mender, Ilgen Et Al. "Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton," INTERNATIONAL JOURNAL OF ONCOLOGY , vol.42, no.5, 1709-1715, 2013
Mender, Ilgen Et Al. "Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton." INTERNATIONAL JOURNAL OF ONCOLOGY , vol.42, no.5, pp.1709-1715, 2013
Mender, I. Et Al. (2013) . "Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton." INTERNATIONAL JOURNAL OF ONCOLOGY , vol.42, no.5, pp.1709-1715.
@article{article, author={Ilgen Mender Et Al. }, title={Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton}, journal={INTERNATIONAL JOURNAL OF ONCOLOGY}, year=2013, pages={1709-1715} }